Share on LinkedInShare on LinkedIn

ARTICLE · 15 MAY 2013

What Constitutes A Human Embryo? - CJEU To Revisit Controversial Issue

Fieldfisher
Fieldfisher
Contributor
Fieldfisher

Fieldfisher

Fieldfisher is a European law firm with market-leading practices in many of the world’s most...

View firm profile
Explore more from Fieldfisher

International Stem Cell Corporation applied to patent a new method for activating an oocyte in the absence of sperm through parthenogenesis.

United KingdomIntellectual Property

On 17 April the UK High Court has made a reference to the Court of Justice of the European Union (“CJEU”), requesting that the term “human embryos” in Article 6(2) of the Directive 98/44/EC, commonly referred to as the Biotech Directive, be clarified.  The referral focuses on whether artificially stimulated ova that are incapable of developing to term should nevertheless be classified as human embryos.

Background

International Stem Cell Corporation (ISCC) applied to patent a new method for activating an oocyte in the absence of sperm through parthenogenesis, the initiation of embryonic cell development without fertilisation, using instead a variety of chemical and electrical techniques.  The technique is viewed as a vital method for producing human embryonic stem cells for research purposes. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from